Anne-Marie Martin

Insider Reports History

Location
One Main Street, Suite 520, Cambridge, MA
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anne-Marie Martin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Therapeutics, Inc. Director Stock Option (Right to Buy) 38.5K Jun 12, 2025 Direct

Insider Reports Filed by Anne-Marie Martin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Therapeutics, Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
CGEM Cullinan Therapeutics, Inc. Jun 26, 2024 1 $0 4 Jun 27, 2024 Director
CGEM Cullinan Oncology, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
CGEM Cullinan Oncology, Inc. Mar 1, 2022 1 $0 4 Mar 2, 2022 Director
CGEM Cullinan Oncology, Inc. Mar 1, 2022 0 $0 3 Mar 2, 2022 Director